ICUI logo

ICUI ICU Medical, Inc.

NASDAQ Global Select · Medical - Instruments & Supplies · Healthcare

$182.98
-0.13 (-0.07%)

ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Inclu…

Market Cap: $4.57Bwww.icumed.com

Price (90d)

$184.56
$117.01$139.53$162.04$184.56
May 1Aug 7

Signal Score (90d)

64
64
Aug 8Aug 8

Quote

Day Range
$181.30 – $183.78
52-Week Range
$112.50 – $192.85
Volume
$190.0K
Market Cap
$4.57B
50-Day Avg
$156.07
200-Day Avg
$142.07
Prev Close
$183.11
Open
$182.25

Valuation & Ratios

P/E Ratio
4803.70
EPS
$0.03
P/B Ratio
1.66
P/S Ratio
1.58
Debt/Equity
0.66
Current Ratio
2.36
Dividend Yield
+0.0%
Gross Margin
+36.8%

Returns & Efficiency

Return on Equity
+0.0%
Return on Assets
+0.0%
FCF Yield
+2.6%
EV/EBITDA
14.09

Revenue & Net Income (Annual)

Fiscal YearRevenueNet IncomeEPS
2025$2.23B$732.0K$0.03
2024$2.38B$-117.69M$-4.83
2023$2.26B$-29.66M$-1.23
2022$2.28B$-74.29M$-3.11
2021$1.32B$103.14M$4.86

Social Signal Score

14
5d
30d
14
1 mentions
+13.8%
60d
14
1 mentions
+29.6%
90d
14
1 mentions
+55.5%
marketaux: 1

Earnings

Thu, Nov 5(in 3 months)

Consensus estimate $2.09 per share

7of 7 quarters beat consensus

Typical surprise +39.8% (median, so one quarter with a near-zero estimate can't distort it)

  • Thu, Aug 6$2.37 vs $1.91beat
  • Thu, May 7$1.97 vs $1.78beat
  • Thu, Feb 19$1.91 vs $1.68beat
  • Thu, Nov 6$2.03 vs $1.43beat
  • Thu, Aug 7$2.10 vs $1.44beat
  • Thu, May 8$1.72 vs $1.23beat

Estimates and results for ICUI via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.

Valuation

Project earnings forward and see what return today's price implies.

Seeded from ICUI's reported EPS growth of -72.0% a year over 4 years. Historical EPS growth of -72% would project the company towards zero. Floored at -15% as a starting point.

EPS in 5 years
$0.01
Implied price
$0.24
Return from $182.98
-73.5% a year

To earn 15.0% a year on these assumptions you'd need to buy at $0.12 -99.9% below today's price.

How sensitive is that answer?

Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.

growth \ P/E1215182124
-25.0%-78.5%-77.5%-76.7%-75.9%-75.3%
-20.0%-77.0%-76.0%-75.1%-74.3%-73.6%
-15.0%-75.6%-74.5%-73.5%-72.7%-72.0%
-10.0%-74.2%-73.0%-72.0%-71.1%-70.3%
-5.0%-72.7%-71.5%-70.4%-69.5%-68.7%

This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.

Mentions (1)

  • News (Marketaux)insidermonkey.com·6d ago·Negative

    Q2 Earnings Blowouts: 37 Stock That Beat Expectations ICU Medical, Inc</[+368 characters]

    View source ↗